Authors:
Cocker, HA
Tiffin, N
Pritchard-Jones, K
Pinkerton, CR
Kelland, LR
Citation: Ha. Cocker et al., In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line, CLIN CANC R, 7(10), 2001, pp. 3193-3198
Authors:
Gordon, T
McManus, A
Anderson, J
Min, T
Swansbury, J
Pritchard-Jones, K
Shipley, J
Citation: T. Gordon et al., Cytogenetic abnormalities in 42 rhabdomyosarcoma: A United Kingdom Cancer Cytogenetics Group Study, MED PED ONC, 36(2), 2001, pp. 259-267
Authors:
Lu, YJ
Williamson, D
Clark, J
Wang, R
Tiffin, N
Skelton, L
Gordon, T
Williams, R
Allan, B
Jackman, A
Cooper, C
Pritchard-Jones, K
Shipley, J
Citation: Yj. Lu et al., Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression, P NAS US, 98(16), 2001, pp. 9197-9202
Authors:
Grundy, R
Anderson, J
Gaze, M
Gerrard, M
Glaser, A
Gordon, A
Malone, M
Pritchard-Jones, K
Michalski, A
Citation: R. Grundy et al., Congenital alveolar rhabdomyosarcoma - Clinical and molecular distinction from alveolar rhabdomyosarcoma in older children, CANCER, 91(3), 2001, pp. 606-612
Authors:
Anderson, J
Gordon, T
McManus, A
Mapp, T
Gould, S
Kelsey, A
McDowell, H
Pinkerton, R
Shipley, J
Pritchard-Jones, K
Citation: J. Anderson et al., Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?, BR J CANC, 85(6), 2001, pp. 831-835
Authors:
Anderson, J
Ramsay, A
Gould, S
Pritchard-Jones, K
Citation: J. Anderson et al., PAX3-FKHR induces morphological change and enhances cellular proliferationand invasion in rhabdomyosarcoma, AM J PATH, 159(3), 2001, pp. 1089-1096
Authors:
Rahman, N
Arbour, L
Houlston, R
Bonaiti-Pellie, C
Abidi, F
Tranchemontagne, J
Ford, D
Narod, S
Pritchard-Jones, K
Foulkes, WD
Schwartz, C
Stratton, MR
Citation: N. Rahman et al., Penetrance of mutations in the familial Wilms tumor gene FWT1, J NAT CANC, 92(8), 2000, pp. 650-652
Authors:
Pritchard-Jones, K
Rahman, N
Gerrard, M
Variend, D
King-Underwood, L
Citation: K. Pritchard-jones et al., Familial Wilms tumour resulting from WT1 mutation: intronic polymorphism causing artefactual constitutional homozygosity, J MED GENET, 37(5), 2000, pp. 377-379
Authors:
Rapley, EA
Barfoot, R
Bonaiti-Pellie, C
Chompret, A
Foulkes, W
Perusinghe, N
Reeve, A
Royer-Pokora, B
Schumacher, V
Shelling, A
Skeen, J
de Tourreil, S
Weirich, A
Pritchard-Jones, K
Stratton, MR
Rahman, N
Citation: Ea. Rapley et al., Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2, BR J CANC, 83(2), 2000, pp. 177-183
Citation: K. Pritchard-jones, Distinguished Career Award of the American Society of Pediatric Hematology/Oncology for 1999 - Alfred G. Knudson, J PED H ONC, 21(4), 1999, pp. 258-258
Authors:
Rahman, N
Abidi, F
Ford, D
Arbour, L
Rapley, E
Tonin, P
Barton, D
Batcup, G
Berry, J
Cotter, F
Davison, V
Gerrard, M
Gray, E
Grundy, R
Hanafy, M
King, D
Lewis, I
Luethy, AR
Madlensky, L
Mann, J
O'Meara, A
Oakhill, T
Skolnick, M
Strong, L
Variend, D
Narod, S
Schwartz, C
Pritchard-Jones, K
Stratton, MR
Citation: N. Rahman et al., Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypiccharacteristics of Wilms' tumour attributable to FWT1, HUM GENET, 103(5), 1998, pp. 547-556